Patterns of Lymph Node Metastases in Apparent Stage I Low-Grade Epithelial Ovarian Cancer: A Multicenter Study
Lucas Minig, Christina Fotopoulou(Ovarian Cancer Action), José Miguel Cárdenas‐Rebollo(Universidad San Pablo CEU), Ignacio Zapardiel(Hospital Universitario La Paz), Marco Petrillo(University of Sassari), Florian Heitz(Kliniken Essen-Mitte), Giovanni Scambia(Agostino Gemelli University Polyclinic), Jamie N. Bakkum‐Gamez(Mayo Clinic in Arizona), Eleftheria Kalogera(Palmetto General Hospital), Andreas du Bois(Kliniken Essen-Mitte), Vanna Zanagnolo(European Institute of Oncology), Sean C. Dowdy(Mayo Clinic), Kristina Lindemann(Oslo University Hospital), David Cibula(Prague University of Economics and Business), Philipp Harter, Anna Germanová(Charles University), Cristina Zorrero(Fundación Instituto Valenciano de Oncología)
Cited by 54
Related Papers
Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancer
|Nature reviews. Cancer|2015|1.4k
ESMO-ESGO-ESTRO Consensus Conference on Endometrial Cancer: diagnosis, treatment and follow-up
|Annals of Oncology|2015|1.4k
ESMO–ESGO consensus conference recommendations on ovarian cancer: pathology and molecular biology, early and advanced stages, borderline tumours and recurrent disease
|Annals of Oncology|2019|1.2k
Newly diagnosed and relapsed epithelial ovarian carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
|Annals of Oncology|2013|1.1k
<scp>FIGO</scp> staging of endometrial cancer: 2023
|International Journal of Gynecology & Obstetrics|2023|926